EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study

Yutaka Sugawara, Momoko Kobayashi, Eri Mannoji, Tomoya Saika, Yuki Kado, Michiko Yamazaki, Tohru Takebe, Hajime Higuchi

Frontiers in Digital Health · 08.06.2026 · 8

DOI: 10.3389/fdgth.2026.1792647 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Digital Health, online erschienen am 08.06.2026. Verfasst von Yutaka Sugawara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, International University of Health and Welfare, Narita Hospital, Chiba, Japan. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Electronic patient-reported outcome (ePRO) systems using the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) can improve symptom monitoring, but the feasibility of implementing such systems with a bring-your-own-device (BYOD) approach in routine oncology practice, particularly among older adults, is not well established. We conducted a single-arm prospective observational study in Japan to evaluate weekly BYOD-based ePRO monitoring of adverse events in outpatients receiving chemotherapy. Twenty-eight patients used smartphones to complete weekly PRO-CTCAE/CTCAE-based questionnaires for 12 weeks. Alerts were automatically generated when severity or frequency thresholds were met. Feasibility outcomes were weekly ePRO response rates and the distribution of alert-generating symptoms; HRQoL (EORTC QLQ-C30) was assessed at baseline, week 6, and week 12. The mean age was 66.7 years and most patients had stage IV disease. The weekly ePRO response rate ranged from 75% to 93% in the overall cohort and remained at or above 75% in patients aged ≥70 years. Pain-related items most frequently triggered alerts, followed by numbness and tingling, rash, fatigue, and skin-related disorders. The EORTC QLQ-C30 global health status score increased numerically from 54.8 at baseline to 63.5 at week 6 and 63.4 at week 12, with no marked deterioration observed over 12 weeks. These findings indicate that weekly PRO-CTCAE/CTCAE-based ePRO monitoring using a BYOD approach is feasible in routine outpatient oncology care, including among older adults who use smartphones. This study provides preliminary evidence for BYOD-based ePRO implementation in this underexplored population.

Schlagwörter

Stichwörter der Autor:innen

PRO-CTCAEbring-your-own-deviceelectronic patient-reported outcomesolder adultsoutpatient oncologysymptom monitoring

Autor:innen und Institutionen

  • Department of Clinical Oncology, International University of Health and Welfare, Narita Hospital, Chiba, Japan.
  • Patient Engagement Frontier Medical Science, KAKEHASHI Inc., Tokyo, Japan.
  • Graduate School of Medical and Pharmaceutical Sciences, Chiba University, Chiba, Japan.
  • Department of Hematology, Nippon Medical School, Tokyo, Japan.

Zitieren

APA

Sugawara, Y., Kobayashi, M., Mannoji, E., Saika, T., Kado, Y., Yamazaki, M., Takebe, T., & Higuchi, H. (2026). Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study. Frontiers in Digital Health, 8. https://doi.org/10.3389/fdgth.2026.1792647

Vancouver

Sugawara Y, Kobayashi M, Mannoji E, Saika T, Kado Y, Yamazaki M, et al. Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study. Frontiers in Digital Health. 2026;8. doi:10.3389/fdgth.2026.1792647

BibTeX
@article{Sugawara2026,
  author = {Sugawara, Yutaka and Kobayashi, Momoko and Mannoji, Eri and Saika, Tomoya and Kado, Yuki and Yamazaki, Michiko and Takebe, Tohru and Higuchi, Hajime},
  title = {Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study},
  journal = {Frontiers in Digital Health},
  year = {2026},
  volume = {8},
  doi = {10.3389/fdgth.2026.1792647}
}
Kostenlos starten →